Ignite Creation Date:
2024-05-06 @ 3:26 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02280785
Status:
COMPLETED
Last Update Posted:
2018-09-06
First Post:
2014-10-05
Brief Title:
Brentuximab Vedotin for RelapsedRefractory CD30-positive Non-Hodgkin Lymphomas
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-05
First Submit QC Date:
October 31 2014
Study First Post Date:
2014-11-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-04
Last Update Post Date:
2018-09-06
Last Update Post Date Type:
ACTUAL